Canada markets closed

BioXcel Therapeutics, Inc. (BTAI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3500-0.1600 (-6.37%)
At close: 04:00PM EDT
2.3100 -0.04 (-1.70%)
After hours: 07:57PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,380
1,380
375
0
0
Cost of Revenue
1,260
1,260
20
0
-
Gross Profit
120
120
355
0
-
Operating Expenses
Research Development
84,326
84,326
91,239
52,708
57,995
Selling General and Administrative
83,413
83,413
68,761
54,228
24,302
Total Operating Expenses
167,739
167,739
160,000
106,936
82,297
Operating Income or Loss
-167,619
-167,619
-159,645
-106,936
-82,297
Interest Expense
13,314
13,314
8,213
40
27
Total Other Income/Expenses Net
-3,769
-3,769
-427
-
155
Income Before Tax
-179,053
-179,053
-165,757
-106,932
-82,169
Income from Continuing Operations
-179,053
-179,053
-165,757
-106,932
-82,169
Net Income
-179,053
-179,053
-165,757
-106,931
-82,169
Net Income available to common shareholders
-179,053
-179,053
-165,757
-106,931
-82,169
Basic EPS
-7.36
-6.15
-5.92
-4.05
-3.79
Diluted EPS
-7.36
-6.15
-5.92
-4.05
-3.79
Basic Average Shares
28,787
29,129
28,015
26,373
21,683
Diluted Average Shares
28,787
29,129
28,015
26,373
21,683